|
CLDND1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
5.69839999964294E-07 |
| Normal-vs-Stage3 |
5.112132939189E-12 |
| Normal-vs-Stage4 |
2.84280043949536E-10 |
| Stage1-vs-Stage2 |
9.826000E-01 |
| Stage1-vs-Stage3 |
4.192800E-01 |
| Stage1-vs-Stage4 |
1.486830E-01 |
| Stage2-vs-Stage3 |
5.915400E-01 |
| Stage2-vs-Stage4 |
3.766200E-01 |
| Stage3-vs-Stage4 |
5.930200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.24519999999506E-05 |
| Normal-vs-Asian |
3.999900E-02 |
| Caucasian-vs-AfricanAmerican |
1.148640E-01 |
| Caucasian-vs-Asian |
3.329800E-01 |
| AfricanAmerican-vs-Asian |
1.531170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
3.575200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.88190000000233E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.99840144432528E-15 |
| Normal-vs-Age(81-100Yrs) |
2.360200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.113800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.085160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.901900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.484000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.363070E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.283700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.639010E-04 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
5.74429392941056E-13 |
| Normal-vs-Grade 4 |
3.61030000006757E-07 |
| Grade 1-vs-Grade 2 |
2.709200E-01 |
| Grade 1-vs-Grade 3 |
1.983590E-03 |
| Grade 1-vs-Grade 4 |
8.682100E-03 |
| Grade 2-vs-Grade 3 |
3.9066000000032E-05 |
| Grade 2-vs-Grade 4 |
4.556000E-03 |
| Grade 3-vs-Grade 4 |
8.831000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
1.88404847278889E-12 |
| ccA subtype-vs-ccB subtype |
1.107910E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
6.20719999999686E-05 |
| N0-vs-N1 |
4.700200E-01 |
|
|
